Thomas Englese - Mar 8, 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (AZYO)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese
Stock symbol
AZYO
Transactions as of
Mar 8, 2022
Transactions value $
$0
Form type
4
Date filed
3/10/2022, 07:46 PM
Previous filing
Dec 15, 2021
Next filing
Sep 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZYO Class A Common Stock Options Exercise $0 +938 +15.78% $0.00 6.88K Mar 8, 2022 Direct F1, F2
transaction AZYO Class A Common Stock Sale -276 -4.01% 6.61K Mar 10, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AZYO Stock Option (Right to Buy) Award $0 +31K $0.00 31K Mar 8, 2022 Class A Common Stock 31K $5.08 Direct F4
transaction AZYO Restricted Stock Units Award $0 +8.7K $0.00 8.7K Mar 8, 2022 Class A Common Stock 8.7K Direct F5, F6
transaction AZYO Restricted Stock Units Options Exercise $0 -938 -25.01% $0.00 2.81K Mar 8, 2022 Class A Common Stock 938 Direct F1, F7
transaction AZYO Restricted Stock Units Award $0 +15.4K $0.00 15.4K Mar 8, 2022 Class A Common Stock 15.4K Direct F5, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis.
F2 Includes 857 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.16 to $5.34. The Reporting Person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4 The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026.
F5 Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.
F6 The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024.
F7 On March 8, 2021, the Reporting Person was granted 3,750 restricted stock units, vesting in four substantially equal annual installments beginning in March 8, 2022.
F8 The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.